ST. LOUIS, Nov. 10 KV Pharmaceutical Company (NYSE: KVa/KVb) announced today that due to the ongoing Audit Committee inquiry previously announced, the Company will be delayed in the filing of its Form ...
KV Pharmaceutical’s petition for Chapter 11 protection, which was filed on Saturday in U.S. Bankruptcy Court for the Southern District of New York in Manhattan, listed the company’s assets as $237 ...
FILE PHOTO: KV Pharmaceutical's former headquarters in Bridgeton. Photo by Emily Rasinski, [email protected] KV Pharmaceutical Co., which filed for bankruptcy in August, has filed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback